Approximately 41 million children under the age of 5 were overweight or obese in 2016, and this number is expected to continue to rise in the coming years, according to the World Health Organization.
Future Market Insights projects the global Pediatric Obesity Management market to grow at a compound annual growth rate (CAGR) of 4% from 2023 to 2033.
One of the most promising innovations in pediatric obesity management is the development of personalized nutrition and exercise plans.
These plans take into account a child's unique needs and preferences, as well as their medical history and any underlying conditions.
Another promising innovation is the use of digital health tools, such as mobile apps and wearable devices, to monitor and manage pediatric obesity.
These tools can help children and their families track their progress, set goals, and receive personalized feedback and support.
Hospital pharmacies are expected to hold the largest market share in the global Pediatric Obesity Management market, with 40% of the market projected to be in North America by the end of the forecast period.
The US Food and Drug Administration approved Wegovy (semaglutide) injection (2.4 mg once weekly) as a medication for chronic weight control in individuals with obesity or those who are overweight with at least one weight-related disease, such as high blood pressure, high cholesterol, or type
Read the Entire Article
A customized collection of news from foundations from around the Web.
iPass, a telecommunications provider, will give free internet access to 100 non-government organizations (NGOs) for a year as they work in dangerous countries to help its poor and underserved populations.